128 related articles for article (PubMed ID: 25766669)
1. Outcomes following implementation of symptom triggered diagnostic testing for ovarian cancer.
Rai N; Nevin J; Downey G; Abedin P; Balogun M; Kehoe S; Sundar S
Eur J Obstet Gynecol Reprod Biol; 2015 Apr; 187():64-9. PubMed ID: 25766669
[TBL] [Abstract][Full Text] [Related]
2. Refining Ovarian Cancer Test accuracy Scores (ROCkeTS): protocol for a prospective longitudinal test accuracy study to validate new risk scores in women with symptoms of suspected ovarian cancer.
Sundar S; Rick C; Dowling F; Au P; Snell K; Rai N; Champaneria R; Stobart H; Neal R; Davenport C; Mallett S; Sutton A; Kehoe S; Timmerman D; Bourne T; Van Calster B; Gentry-Maharaj A; Menon U; Deeks J;
BMJ Open; 2016 Aug; 6(8):e010333. PubMed ID: 27507231
[TBL] [Abstract][Full Text] [Related]
3. Estimating the workload associated with symptoms-based ovarian cancer screening in primary care: an audit of electronic medical records.
Lim AW; Mesher D; Sasieni P
BMC Fam Pract; 2014 Dec; 15():200. PubMed ID: 25496012
[TBL] [Abstract][Full Text] [Related]
4. Urgent GP referrals for suspected lung, colorectal, prostate and ovarian cancer.
Allgar VL; Neal RD; Ali N; Leese B; Heywood P; Proctor G; Evans J
Br J Gen Pract; 2006 May; 56(526):355-62. PubMed ID: 16638251
[TBL] [Abstract][Full Text] [Related]
5. Two week waits: What are we waiting for?
Abdelraheim AR; Khairy M; Mohammed M; Lawrence A
Eur J Obstet Gynecol Reprod Biol; 2017 Aug; 215():112-117. PubMed ID: 28609712
[TBL] [Abstract][Full Text] [Related]
6. Stage, survival and delays in lung, colorectal, prostate and ovarian cancer: comparison between diagnostic routes.
Neal RD; Allgar VL; Ali N; Leese B; Heywood P; Proctor G; Evans J
Br J Gen Pract; 2007 Mar; 57(536):212-9. PubMed ID: 17359608
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic performance of urgent referrals for suspected gynaecological malignancies.
Burbos N; Musonda P; Rufford B
Arch Gynecol Obstet; 2011 Dec; 284(6):1495-500. PubMed ID: 21331542
[TBL] [Abstract][Full Text] [Related]
8. One-stop clinic for patients with suspected ovarian cancer: results from a retrospective outcome study of the referral pathway.
Ashmore AA; Gnanachandran C; Luqman I; Horrocks K
BMC Womens Health; 2021 Dec; 21(1):429. PubMed ID: 34961545
[TBL] [Abstract][Full Text] [Related]
9. Ovarian cancer suspicion, urgent referral and time to diagnosis in Danish general practice: a population-based study.
Baun ML; Jensen H; Falborg AZ; Heje HN; Petersen LK; Vedsted P
Fam Pract; 2019 Nov; 36(6):751-757. PubMed ID: 31046091
[TBL] [Abstract][Full Text] [Related]
10. Pathways to the diagnosis of ovarian cancer in the UK: a cohort study in primary care.
Barrett J; Sharp DJ; Stapley S; Stabb C; Hamilton W
BJOG; 2010 Apr; 117(5):610-4. PubMed ID: 20121830
[TBL] [Abstract][Full Text] [Related]
11. Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study.
Rosenthal AN; Fraser LSM; Philpott S; Manchanda R; Burnell M; Badman P; Hadwin R; Rizzuto I; Benjamin E; Singh N; Evans DG; Eccles DM; Ryan A; Liston R; Dawnay A; Ford J; Gunu R; Mackay J; Skates SJ; Menon U; Jacobs IJ;
J Clin Oncol; 2017 May; 35(13):1411-1420. PubMed ID: 28240969
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of women referred to the two-week wait gynaecology clinic with suspected ovarian cancer.
Jeffery HE; Gillespie AM; Macdonald M
Eur J Obstet Gynecol Reprod Biol; 2021 Nov; 266():145-149. PubMed ID: 34653919
[TBL] [Abstract][Full Text] [Related]
13. Adherence to practice guidelines is associated with reduced referral times for patients with ovarian cancer.
Boac BM; Xiong Y; Apte SM; Wenham RM; Shahzad MM; Munroe DG; Lancaster JM; Chon HS
Am J Obstet Gynecol; 2018 Apr; 218(4):436.e1-436.e7. PubMed ID: 29353030
[TBL] [Abstract][Full Text] [Related]
14. Prospective Cohort of Referrals to a Cancer of Unknown Primary Clinic, including Direct Access from Primary Care.
Creak A
Clin Oncol (R Coll Radiol); 2020 Apr; 32(4):e87-e92. PubMed ID: 31635979
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of screening for ovarian cancer using symptoms as selection criteria.
Rufford BD; Jacobs IJ; Menon U
BJOG; 2007 Jan; 114(1):59-64. PubMed ID: 17233861
[TBL] [Abstract][Full Text] [Related]
16. Primary-to-secondary care referral experience of suspected colorectal malignancy in young adults.
Patel K; Doulias T; Hoad T; Lee C; Alberts JC
Ann R Coll Surg Engl; 2016 May; 98(5):308-13. PubMed ID: 27023637
[TBL] [Abstract][Full Text] [Related]
17. Value of symptom-triggered diagnostic evaluation for ovarian cancer.
Andersen MR; Lowe KA; Goff BA
Obstet Gynecol; 2014 Jan; 123(1):73-79. PubMed ID: 24463666
[TBL] [Abstract][Full Text] [Related]
18. Outcome of elevated CA125 values from primary care following implementation of ovarian cancer guidelines.
Crawford SM; Evans C
Fam Pract; 2018 Mar; 35(2):199-202. PubMed ID: 29029123
[TBL] [Abstract][Full Text] [Related]
19. Assessment of symptomatic women for early diagnosis of ovarian cancer: results from the prospective DOvE pilot project.
Gilbert L; Basso O; Sampalis J; Karp I; Martins C; Feng J; Piedimonte S; Quintal L; Ramanakumar AV; Takefman J; Grigorie MS; Artho G; Krishnamurthy S;
Lancet Oncol; 2012 Mar; 13(3):285-91. PubMed ID: 22257524
[TBL] [Abstract][Full Text] [Related]
20. The National Institute for Health and Clinical Excellence (NICE) guidelines for early detection of ovarian cancer: the pivotal role of the clinical laboratory.
Sturgeon CM; Duffy MJ; Walker G
Ann Clin Biochem; 2011 Jul; 48(Pt 4):295-9. PubMed ID: 21746796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
